Abstract:Importance: Despite posing a significant challenge to global tuberculosis (TB) elimination efforts, recurrent TB remains understudied due to the challenges of long-term observation. Objective: To investigate the burden of recurrent TB using data from patients with pulmonary TB (PTB) in China. Design, setting, and participants: This retrospective cohort study included all bacteriologically confirmed or clinically diagnosed PTB cases reported to the Tuberculosis Information Management System with completed or successful treatment outcomes from January 1, 2005, to December 31, 2021. Data were analyzed from July 15, 2022, to October 28, 2023. Exposures: Newly diagnosed PTB was classified into primary, hematogenous disseminated, or secondary PTB. Main outcomes and measures: The primary outcome was the annual recurrence rate, stratified by disease classification, over the 17-year observation period. The recurrence rate for year n was calculated by dividing the number of patients with recurrent TB in year n by observed person-years in year n. The secondary outcome was the annual proportion of recurrent TB among reported cases and associated risk factors. Results: Of 13 833 249 patients with TB reported to the Tuberculosis Information Management System, 10 482 271 with PTB met the inclusion criteria. Of these, 68.9% were male, 22.3% were 65 years or older, 89.6% were of Han ethnicity, and 68.4% were agricultural workers. A total of 413 936 patients experienced a recurrent TB episode after successful treatment, resulting in an overall recurrence rate of 0.47 (95% CI, 0.47-0.48) per 100 person-years. The recurrence rate for patients with primary PTB was 0.24 (95% CI, 0.22-0.26) per 100 person-years; for hematogenous disseminated PTB, 0.37 (95% CI, 0.36-0.38) per 100 person-years; and for secondary PTB, 0.48 (95% CI, 0.47-0.48) per 100 person-years. The cumulative proportion of recurrences within the first 2 years accounted for 48.9% of all recurrent cases. The proportion of recurrent cases among notified incident cases increased 1.9-fold from 4.7% in 2015 to 8.8% in 2021. Among other factors, ages 45 to 64 years (adjusted hazard ratio, 1.77 [95% CI, 1.65-1.89]) and having completed treatment (adjusted hazard ratio, 1.16 [95% CI, 1.14-1.18]) were identified as associated with recurrence. Conclusions and relevance: In this retrospective cohort study, the PTB recurrence rate was substantially higher than the incidence, and the proportion of recurrent cases increased. Almost half of the recurrence occurred within the first 2 years, suggesting that routine posttreatment follow-up may represent an important strategy for accelerating TB elimination.

How Do Smoking Status and Smoking Cessation Efforts Affect TB Recurrence after Successful Completion of Anti-TB Treatment? A Multicenter, Prospective Cohort Study with a 7-Year Follow-up in China.

Smoking cessation to prevent death and tuberculosis recurrence after treatment: A prospective cohort study with a seven-year follow-up in China

Tuberculosis Recurrence over a 7-Year Follow-Up Period in Successfully Treated Patients in a Routine Program Setting in China: a Prospective Longitudinal Study

Recurrent pulmonary tuberculosis after treatment success: a population-based retrospective study in China

Treatment and recurrence on re-treatment tuberculosis patients: a randomized clinical trial and 7-year perspective cohort study in China

Epidemiology of Recurrent Pulmonary Tuberculosis in Henan Province, China: Observational study (Preprint)

Recurrent Pulmonary Tuberculosis in China, 2005 to 2021

Short-course Regimen for Subsequent Treatment of Pulmonary Tuberculosis: A Prospective, Randomized, Controlled Multicenter Clinical Trial in China.

Tuberculosis reinfection and relapse in eastern China: a prospective study using whole-genome sequencing

The prediction model for short-term recurrence after cured in initial-smear-positive pulmonary tuberculosis

Treatment Outcomes and Factors Affecting Unsuccessful Outcome among New Pulmonary Smear Positive and Negative Tuberculosis Patients in Anqing, China: a Retrospective Study.

Risk Factors and Biomarkers for Post-Tuberculosis Lung Damage in a Chinese Cohort of Male Smokers and Non-Smokers: Protocol for a Prospective Observational Study.

Endogenous Relapse and Exogenous Reinfection in Recurrent Pulmonary Tuberculosis: A Retrospective Study Revealed by Whole Genome Sequencing

Factors associated with treatment outcomes of patients with drug-resistant tuberculosis in China: A retrospective study using competing risk model

Recurrent Tuberculosis in an Urban Area in China: Relapse or Exogenous Reinfection?

Factors Associated with Loss to Follow-Up Before and after Treatment Initiation among Patients with Tuberculosis: A 5-Year Observation in China

Patients at high risk of tuberculosis recurrence

Effect of Different Interventions for Latent Tuberculosis Infections in China: a Model-Based Study

Impact of alcohol drinking and tobacco smoking on the drug-resistance of newly diagnosed tuberculosis: a retrospective cohort study in Shandong, China, during 2004-2020

A Modeling Study Recurrent Tuberculosis Towards End TB Strategy - China, 2025-2035

The effect of smoking on nontuberculous mycobacterial pulmonary disease and tuberculosis: a nationwide retrospective cohort study